CoChat

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Open access
Jian, Chongshu, Fu, Jiajun, Cheng, Xu, Shen, Li-Jun, Ji, Yan-Xiao, Wang, Xiaoming, Pan, Shan, Tian, Han, Tian, Song, Liao, Rufang, Song, Kehan, Wang, Hai-Ping, Zhang, Xin, Wang, Yibin, Huang, Zan, She, Zhi-Gang, Zhang, Xiao-Jing, Zhu, Lihua, Li, Hongliang · 2020 · Cell Metabolism
Cited by 171

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

SUMMARY Nonalcoholic steatohepatitis (NASH) is becoming one of the leading causes of hepatocellular carcinoma (HCC). Sorafenib is the only first-line therapy for advanced HCC despite its serious adverse effects. Here, we report that at an equivalent of approximately one-tenth the clinical dose for HCC, sorafenib treatment effectively prevents the progression of NASH in both mice and monkeys without any observed significant adverse events. Mechanistically, sorafenib’s benefit in NASH is independent of its canonical kinase targets in HCC, but involves the induction of mild mitochondrial uncoupling and subsequent activation of AMP–activated protein kinase (AMPK). Collectively, our findings demonstrate a previously unappreciated therapeutic effect and signaling mechanism of low-dose sorafenib treatment in NASH. We envision that this new therapeutic strategy for NASH has the potential to translate into a beneficial anti-NASH therapy with fewer adverse events than is observed in the drug’s current use in HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2020.04.011

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 171

Metadata

Authors
Jian, C., Fu, J., Cheng, X., Shen, L.-J., Ji, Y.-X., Wang, X., Pan, S., Tian, H., Tian, S., Liao, R., Song, K., Wang, H.-P., Zhang, X., Wang, Y., Huang, Z., She, Z.-G., Zhang, X.-J., Zhu, L., & Li, H.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2020-05
Volume
31
Issue
5
Pages
892-908.e11
ISSN
1550-4131 (ISSN-L)
OpenAlex
W3022051450
Cited by
171
References
19
FWCI
13.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis. https://app.cochat.ai/papers/10.1016/j.cmet.2020.04.011
The paper
Jian, C., Fu, J., Cheng, X., Shen, L.-J., Ji, Y.-X., Wang, X., Pan, S., Tian, H., Tian, S., Liao, R., Song, K., Wang, H.-P., Zhang, X., Wang, Y., Huang, Z., She, Z.-G., Zhang, X.-J., Zhu, L., & Li, H. (2020). Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis. Cell Metabolism. https://doi.org/10.1016/j.cmet.2020.04.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.